JFL LIFE SCIENCES Stock Price Today (NSE: JFLLIFE)
Fundamental Score
JFL LIFE SCIENCES Share Price Live NSE/BSE & Institutional Fundamental Analysis
JFL LIFE SCIENCES share price today is ₹10.90, up +0.00% on NSE/BSE as of 19 February 2026. JFL LIFE SCIENCES (JFLLIFE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹39.59 (Cr). The 52-week high for JFLLIFE share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 11.18x, JFLLIFE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 11.09% and a debt-to-equity ratio of 0.27.
JFL LIFE SCIENCES Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
JFL LIFE SCIENCES Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
JFL LIFE SCIENCES Share Price: A Conservative Value Investor's Perspective
The pharmaceutical sector, while potentially lucrative, demands careful scrutiny. Government regulations, R&D expenditures, and patent cliffs create inherent volatility, making capital preservation paramount. This analysis examines the JFL LIFE SCIENCES share price (currently ₹10.95) through the lens of a conservative value investor focused on downside protection. A key metric under consideration is the company’s Price-to-Earnings (PE) ratio of 11.18.
The observed PE ratio suggests a potentially undervalued scenario, especially when compared against broader market averages. However, a low PE in isolation provides insufficient justification for investment. A rigorous examination of financial health and competitive positioning is essential. One aspect of our 80-parameter fundamental audit, verified by Sweta Mishra, includes a comparative analysis of management quality. While difficult to quantify directly, anecdotal evidence suggests that
Mankind Pharma Ltd generally benefits from a more experienced and strategically focused leadership team. This difference in perception impacts long-term growth expectations and investor confidence.JFL LIFE SCIENCES exhibits a Return on Capital Employed (ROCE) of 15.81%. This is a positive indicator, suggesting efficient capital allocation and profitability. The ROCE sheds light on the company's potential moat. Consistently high ROCE figures can indicate a durable competitive advantage, such as brand recognition or cost efficiency. In JFL's case, sustaining this ROCE over the long term is crucial for building shareholder value. Monitoring this metric alongside industry peers is critical to understanding JFL's ability to maintain its competitive position.
Further investigation into JFL LIFE SCIENCES' balance sheet, cash flow statement, and competitive landscape is necessary before forming a comprehensive assessment. Factors such as debt levels, inventory turnover, and the stability of earnings must be thoroughly analyzed to ensure capital safety. This is an observational analysis based on publicly available data, and further due diligence is recommended.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
JFL LIFE SCIENCES Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JFLLIFE across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Excellent ROCE Performance (15.81%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 11.18 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (35.86%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (22.15% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (63.14% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.27)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (5.40x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (67.47%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Revenue Contraction (-24.30%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-14.56% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-17.42 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
JFL LIFE SCIENCES Financial Statements
Comprehensive financial data for JFL LIFE SCIENCES including income statement, balance sheet and cash flow
About JFLLIFE (JFL LIFE SCIENCES)
JFL LIFE SCIENCES (JFLLIFE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹39.59 (Cr). JFL LIFE SCIENCES has delivered a Return on Equity (ROE) of 11.09% and a ROCE of 15.81%. The debt-to-equity ratio stands at 0.27, reflecting the company's capital structure. Investors tracking JFLLIFE share price can monitor key metrics including P/E ratio, promoter holding of 67.47%, and quarterly earnings growth.
Company Details
JFLLIFE Share Price: Frequently Asked Questions
What is the current share price of JFL LIFE SCIENCES (JFLLIFE)?
As of 19 Feb 2026, 10:12 am IST, JFL LIFE SCIENCES share price is ₹10.90. The JFLLIFE stock has a market capitalisation of ₹39.59 (Cr) on NSE/BSE.
Is JFLLIFE share price Overvalued or Undervalued?
JFLLIFE share price is currently trading at a P/E ratio of 11.18x, compared to the industry average of 31.77x. Based on this relative valuation, the JFL LIFE SCIENCES stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of JFLLIFE share price?
The 52-week high of JFLLIFE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the JFL LIFE SCIENCES share price?
Key factors influencing JFLLIFE share price include quarterly earnings growth (Sales Growth: -24.30%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is JFL LIFE SCIENCES a good stock for long-term investment?
JFL LIFE SCIENCES shows a 5-year Profit Growth of 63.14% and an ROE of 11.09%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.27 before investing in JFLLIFE shares.
How does JFL LIFE SCIENCES compare with its industry peers?
JFL LIFE SCIENCES competes with major peers in the Pharmaceuticals. Investors should compare JFLLIFE share price P/E of 11.18x and ROE of 11.09% against the industry averages to determine competitive standing.
What is the P/E ratio of JFLLIFE and what does it mean?
JFLLIFE share price has a P/E ratio of 11.18x compared to the industry average of 31.77x. Investors pay ₹11 for every ₹1 of annual earnings.
How is JFLLIFE performing according to Bull Run's analysis?
JFLLIFE has a Bull Run fundamental score of 57.1/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does JFLLIFE belong to?
JFLLIFE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting JFL LIFE SCIENCES share price.
What is Return on Equity (ROE) and why is it important for JFLLIFE?
JFLLIFE has an ROE of 11.09%, which shows decent profitability but room for improvement. ROE measures how efficiently JFL LIFE SCIENCES generates profits from shareholders capital.
How is JFLLIFE debt-to-equity ratio and what does it indicate?
JFLLIFE has a debt-to-equity ratio of 0.27, which indicates conservative financing with low financial risk.
What is JFLLIFE dividend yield and is it a good dividend stock?
JFLLIFE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in JFL LIFE SCIENCES shares.
How has JFLLIFE share price grown over the past 5 years?
JFLLIFE has achieved 5-year growth rates of: Sales Growth 22.15%, Profit Growth 63.14%, and EPS Growth -14.56%.
What is the promoter holding in JFLLIFE and why does it matter?
Promoters hold 67.47% of JFLLIFE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in JFL LIFE SCIENCES.
What is JFLLIFE market capitalisation category?
JFLLIFE has a market capitalisation of ₹40 crores, placing it in the Small-cap category.
How volatile is JFLLIFE stock?
JFLLIFE has a beta of N/A. A beta > 1 suggests the JFL LIFE SCIENCES stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is JFLLIFE operating profit margin trend?
JFLLIFE has a 5-year average Operating Profit Margin (OPM) of 10.19%, indicating the company's operational efficiency.
How is JFLLIFE quarterly performance?
Recent quarterly performance shows JFL LIFE SCIENCES YoY Sales Growth of -24.30% and YoY Profit Growth of 35.86%.
What is the institutional holding pattern in JFLLIFE?
JFLLIFE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the JFL LIFE SCIENCES stock.